Sera Q3 revenue $16k, net loss $7.8M; launches Medicaid pilot in Nevada

SERA PROGNOSTICS, INC.

2025-Q3 EPS reported -$0.51 revenue$71,000

Revenue $16k vs $29k YoY; net loss $7.8M vs $7.9M; cash $102.4M funds operations through 2028.
Inaugural Medicaid pilot launched in Nevada; payer discussions across 13 states covering 33% of U.S. births.
PRIME study full results on track for publication in 2025; health economic data also forthcoming.
Appointed Dr. Tiffany Inglis as CMO and Marisol Urbano as Head of Commercial Operations.
SG&A rose to $5.7M from $5.4M due to commercial investments; R&D fell to $3.3M as PRIME study concluded.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.